Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population‐based case‐control study-Reference-Cited by-同舟云学术

Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population‐based case‐control study

Author:

Hálfdánarson Óskar Ö.¹^ORCID,Fall Katja²³,Ogmundsdottir Margret H.⁴,Lund Sigrún H.¹,Steingrímsson Eiríkur⁴,Ogmundsdottir Helga M.⁵,Zoega Helga¹⁶

Affiliation:

1. Centre of Public Health Sciences, Faculty of MedicineUniversity of Iceland Reykjavík Iceland

2. Clinical Epidemiology and Biostatistics, School of Medical SciencesÖrebro University Örebro Sweden

3. Department of Medical Epidemiology and BiostatisticsKarolinska Institutet Stockholm Sweden

4. Department of Biochemistry and Molecular Biology, BioMedical Center, Faculty of MedicineUniversity of Iceland Reykjavik Iceland

5. Cancer Research Laboratory, BioMedical Center, Faculty of MedicineUniversity of Iceland Reykjavik Iceland

6. Medicines Policy Research Unit, Centre for Big Data Research in HealthUniversity of New South Wales Sydney Australia

Funder

Icelandic Research Fund

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

Reference61 articles.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献